Drugs & Targets FDA Grants Accelerated Approval to Ibrance In HER2-Negative Metastatic Breast Cancer February 26, 2015Vol.38 No.02
TCGA Researchers Discover Genomic Differences in Cancers Caused by Infection February 26, 2015Vol.38 No.02
Study: Lymphoseek Patients Had Fewer Sentinel Lymph Nodes Removed Per Procedure February 26, 2015Vol.38 No.02
Cranial Irradiation Can Increase Risk of Pituitary Deficiencies Later in Life, Study Says February 26, 2015Vol.38 No.02
Imbruvica Demonstrates 88% Response Rate In Studies of Relapsed/Refractory CLL Patients February 26, 2015Vol.38 No.02
Gazyva Increases PFS in Phase III Trial Of Indolent Non-Hodgkin’s Lymphoma Patients February 26, 2015Vol.38 No.02
